Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ustekinumab for Intestinal Behçet's Syndrome Complicated by Myelodysplastic Syndrome

NCT07582991 is registered in ClinicalTrials.gov with Liu Tian as lead sponsor.

NCT NCT07582991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07582991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ustekinumab for Intestinal Behçet's Syndrome Complicated by Myelodysplastic Syndrome
Lead sponsor
Liu Tian
Phase
Phase 2
Overall status
Completed
Start date
March 24, 2024
Completion date
February 23, 2026
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behcet's syndrome, intestinal type, myelodysplastic syndrome